Core Laboratories N.V.

$ 11.69 2.27 %

Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.

CEO: Lawrence V. Bruno - https://www.corelab.com

Price objectif

$25 113.86 %

Recommandation

Hold

DCF

$ 16.83

Loading data...

CLB vs S&P500

Loading data...

No data available.

Quick ratio

1.50

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

19.16

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.61

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

10.74 %

reflects reasonable profitability, showing good use of equity.

ROIC

7.51 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

7.85

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.62

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.41

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

6.51 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
2.86 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.22 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.29 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.